CCB
GH icon

Cutter & Co Brokerage’s Guardant Health GH Stock Holding History

Cutter & Co Brokerage’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-8,760
Closed -$756K – 305
2019
Q2 		$756K Buy
8,760
+3,120
+55% +$238K 0.24% 100
2019
Q1 		$433K Buy
+5,640
New +$313K 0.12% 157

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cutter & Co Brokerage's GH Position: Q3 2019 in Review

Cutter & Co Brokerage sold out of Guardant Health (GH) in Q3 2019, closing a stake of 8,760 shares — an estimated $756K sold.

Cutter & Co Brokerage first reported a position in GH in Q1 2019 and held it in 2 quarters. The position peaked at $756K in Q2 2019. 242 funds tracked by Wall St. Rank hold GH as of Q3 2019.

  • Cutter & Co Brokerage reported no remaining Guardant Health position as of Q3 2019 after selling out during the quarter.
  • Cutter & Co Brokerage sold 8,760 Guardant Health shares in Q3 2019, an estimated $756K.
  • Cutter & Co Brokerage first reported a position in Guardant Health in Q1 2019 and held it in 2 quarters.
  • Cutter & Co Brokerage's Guardant Health position peaked at $756K in Q2 2019.
  • 242 funds tracked by Wall St. Rank held Guardant Health as of Q3 2019.

Based on Cutter & Co Brokerage's 13F filing for Q3 2019, filed 7 Nov 2019.